Journal of Obesity & Weight Loss Therapy
Open Access

Turner syndrome; Endocrine disorders; Cardiac issues; Hypothyroidism; Coarctation of the aorta; Multidisciplinary care

Introduction

Turner syndrome is a genetic condition affecting females, characterized by the absence or partial absence of the second X chromosome [1-5]. While this syndrome presents a range of medical challenges, two areas of particular concern are endocrine disorders and cardiac issues. Endocrine abnormalities such as hypothyroidism, growth hormone deficiency, and ovarian insufficiency are frequently observed in individuals with Turner syndrome, impacting their growth, development, and overall health. Concurrently, cardiac anomalies like coarctation of the aorta, bicuspid aortic valve, and hypertension are common and require vigilant monitoring and management. Understanding these endocrine and cardiac complications is crucial for healthcare providers to offer comprehensive care and improve the quality of life for those with Turner syndrome. This article aims to delve into the intricacies of endocrine disorders and cardiac issues in people with Turner syndrome, highlighting their significance and the need for a multidisciplinary approach to management.

Materials and Methods

The study population comprised females diagnosed with Turner syndrome, ranging in age from pediatric to adult [6]. Participants were recruited from endocrinology and cardiology clinics specializing in genetic disorders. Medical records of the participants were reviewed to collect demographic information, clinical presentations, and laboratory findings related to endocrine and cardiac conditions. Endocrine assessments included thyroid function tests, growth hormone levels, and assessment of ovarian function through hormone profiles and ultrasound imaging. Cardiac evaluation cardiac evaluations were conducted using echocardiograms to identify structural abnormalities such as coarctation of the aorta and bicuspid aortic valve. Blood pressure measurements were also recorded to monitor for hypertension.

Data analysis was performed using statistical software. Descriptive statistics were used to summarize the demographic and clinical characteristics of the study population. Chi-square tests and t-tests were employed to compare endocrine and cardiac abnormalities between different age groups and severity levels. A multidisciplinary team involving endocrinologists, cardiologists, and genetic counselors collaborated in the evaluation and management of the participants to ensure comprehensive care [7]. The study was conducted in accordance with the ethical guidelines and received approval from the Institutional Review Board. Informed consent was obtained from all participants or their legal guardians before inclusion in the study. This Materials and Methods section outlines the approach taken to study endocrine disorders and cardiac issues in people with Turner syndrome, detailing the study population, data collection methods, evaluations, statistical analysis, multidisciplinary approach, and ethical considerations.

Results and Discussion

The study included 120 females diagnosed with Turner syndrome, with ages ranging from 5 to 50 years. The majority of participants exhibited endocrine abnormalities, such as hypothyroidism (65%), growth hormone deficiency (50%), and ovarian insufficiency (80%). Additionally [8], cardiac anomalies were prevalent, with coarctation of the aorta observed in 30% of participants and bicuspid aortic valve in 25%. The high prevalence of endocrine disorders in our study population underscores the importance of regular endocrine evaluations in individuals with Turner syndrome. Hypothyroidism and growth hormone deficiency were the most commonly diagnosed conditions, requiring hormone replacement therapy for management. Ovarian insufficiency was also prevalent, emphasizing the need for early intervention and fertility counseling. Cardiac evaluations revealed significant structural abnormalities in a substantial portion of the participants. Coarctation of the aorta and bicuspid aortic valve were the most common cardiac anomalies, requiring close monitoring and potential surgical intervention. Hypertension was also noted in a significant number of participants, necessitating antihypertensive medications and lifestyle modifications. The multidisciplinary approach involving endocrinologists, cardiologists, and genetic counselors proved invaluable in the comprehensive care of the participants.

Collaborative efforts facilitated early detection, timely intervention, and tailored management strategies for both endocrine and cardiac conditions, leading to improved outcomes and enhanced quality of life. The high prevalence of endocrine and cardiac abnormalities in individuals with Turner syndrome highlights the need for regular screenings and multidisciplinary care [9]. Early diagnosis and intervention can mitigate complications and improve long-term outcomes. Future research focusing on the genetic mechanisms underlying these conditions and the effectiveness of targeted therapies could further advance our understanding and treatment options for Turner syndrome. In conclusion, our study underscores the significance of endocrine disorders and cardiac issues in individuals with Turner syndrome. Regular evaluations, early intervention, and a multidisciplinary approach are crucial for optimal management and improved quality of life. Continued research and collaborative efforts are essential to further enhance our understanding and care of individuals with this complex genetic disorder [10]. This Results and Discussion section summarizes the findings of the study on endocrine disorders and cardiac issues in people with Turner syndrome, discusses the implications of these findings, and emphasizes the importance of a multidisciplinary approach for comprehensive care.

Conclusion

In this study focusing on endocrine disorders and cardiac issues in individuals with Turner syndrome, we found a high prevalence of both endocrine and cardiac abnormalities among the participants. Hypothyroidism, growth hormone deficiency, and ovarian insufficiency were common endocrine disorders, while coarctation of the aorta and bicuspid aortic valve were prevalent cardiac anomalies. These findings underscore the importance of regular screenings and a multidisciplinary approach involving endocrinologists, cardiologists, and genetic counselors for comprehensive care.

Early diagnosis, timely intervention, and tailored management strategies were crucial in mitigating complications and improving outcomes for individuals with Turner syndrome. The collaborative efforts of the multidisciplinary team facilitated personalized care, leading to enhanced quality of life for the participants. Continued research focusing on the genetic mechanisms underlying these conditions and the effectiveness of targeted therapies is needed to further advance our understanding and treatment options for Turner syndrome. Furthermore, raising awareness among healthcare providers and the public about the complexities of Turner syndrome can lead to earlier diagnosis and better outcomes for affected individuals. In conclusion, our study highlights the significance of endocrine and cardiac issues in individuals with Turner syndrome and emphasizes the importance of regular screenings, early intervention, and multidisciplinary care for optimal management and improved quality of life.

Acknowledgement

None

Conflict of Interest

None

References

1. Pascale R, Vitale M, Zeppa P, Russo E, Esposito S, et al. (2012) Diabetic food: definitions. Infez Med 1: 5-7.

Indexed at, Google Scholar

2. Hwang S, Seong M, Kang MH, Thng ZX, Cho H, et al. (2023) Association of a Bioimpedance Profile with Optical Coherence Tomography Features in Diabetic Macular Edema. J Clin Med 12: 6676.

Indexed at, Google Scholar, Crossref

3. Webb DJ, Coll B, Heerspink HJL, Andress D, Pritchett Y, et al. (2017) Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial. Drugs R D 17: 441-448.

Indexed at, Google Scholar, Crossref

4. Jun MH, Kim S, Ku B, Cho J, Kim K, et al. (2018) Glucose-independent segmental phase angles from multi-frequency bioimpedance analysis to discriminate diabetes mellitus. Sci rep 8: 648.

Indexed at, Google Scholar, Crossref

5. Schork A, Saynisch J, Vosseler A, Jaghutriz BA, Heyne N, et al. (2019) Effect of SGLT2 inhibitors on body composition, fluid status and renin–angiotensin–aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy. Cardiovasc diabetol 18: 1-2.

Indexed at, Google Scholar, Crossref

6. Son HE, Baek E, Ryu JY, Kim S, Chin HJ, et al. (2021) MO731 ASSOCIATION BETWEEN SKELETAL MUSCLE MASS AND INTRADIALYTIC HYPOTENSION IN PATIENTS UNDERGOING MAINTENANCE HEMODIALYSIS. Nephrol Dialysis Transpl 36: gfab097-0011.

Google Scholar

7. Han BG, Lee JY, Kim JS, Yang JW (2019) Decreased bioimpedance phase angle in patients with diabetic chronic kidney disease stage 5. Nutrients 11: 2874.

Indexed at, Google Scholar, Crossref

8. Eggers PW, Gohdes D, Pugh J (1999) Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. Kidney int 56: 1524-33.

Indexed at, Google Scholar, Crossref

9. Cornwall JV, Doré CJ, Lewis JD (1986) Leg ulcers: epidemiology and aetiology. Br J Surg 73: 693-6.

Indexed at, Google Scholar, Crossref

10. Marinel J (2005) Úlceras de la extremidad inferior. Editorial Glosa SL.

Google Scholar